LinkChem Co., Ltd. announced that it will receive CNY 117,000,000 in an equity round of funding on April 18, 2022. The transaction will include participation from Jiangxi Fushine Pharmaceutical Co., Ltd. The investor will sign capital increase agreement with the company and its existing shareholders. Post completion of the transaction, the investor will hold 3.9% stake in the company.

Pursuant to the transaction, CNY 811,655 will go to the registered capital and the registered capital of the company will increase from CNY 20,000,000 to CNY 20,811,655. The transaction has been approved at the 2nd session of the investor's 4th directorate.